Matches in Wikidata for { <http://www.wikidata.org/entity/Q37406658> ?p ?o ?g. }
Showing items 1 to 78 of
78
with 100 items per page.
- Q37406658 description "article científic" @default.
- Q37406658 description "article scientifique" @default.
- Q37406658 description "articolo scientifico" @default.
- Q37406658 description "artigo científico" @default.
- Q37406658 description "artículu científicu espublizáu en 2009" @default.
- Q37406658 description "bilimsel makale" @default.
- Q37406658 description "scientific article published on 05 March 2009" @default.
- Q37406658 description "vedecký článok" @default.
- Q37406658 description "vetenskaplig artikel" @default.
- Q37406658 description "videnskabelig artikel" @default.
- Q37406658 description "vědecký článek" @default.
- Q37406658 description "wetenschappelijk artikel" @default.
- Q37406658 description "wissenschaftlicher Artikel" @default.
- Q37406658 description "наукова стаття, опублікована в березні 2009" @default.
- Q37406658 description "научни чланак" @default.
- Q37406658 description "مقالة علمية نشرت في 05 مارس 2009" @default.
- Q37406658 name "Trastuzumab combined with pegylated liposomal doxorubicin in patients with metastatic breast cancer. phase II Study of the Hellenic Cooperative Oncology Group (HeCOG) with biomarker evaluation." @default.
- Q37406658 name "Trastuzumab combined with pegylated liposomal doxorubicin in patients with metastatic breast cancer. phase II Study of the Hellenic Cooperative Oncology Group (HeCOG) with biomarker evaluation." @default.
- Q37406658 name "Trastuzumab combined with pegylated liposomal doxorubicin in patients with metastatic breast cancer. phase II Study of the Hellenic Cooperative Oncology Group" @default.
- Q37406658 type Item @default.
- Q37406658 label "Trastuzumab combined with pegylated liposomal doxorubicin in patients with metastatic breast cancer. phase II Study of the Hellenic Cooperative Oncology Group (HeCOG) with biomarker evaluation." @default.
- Q37406658 label "Trastuzumab combined with pegylated liposomal doxorubicin in patients with metastatic breast cancer. phase II Study of the Hellenic Cooperative Oncology Group (HeCOG) with biomarker evaluation." @default.
- Q37406658 label "Trastuzumab combined with pegylated liposomal doxorubicin in patients with metastatic breast cancer. phase II Study of the Hellenic Cooperative Oncology Group" @default.
- Q37406658 prefLabel "Trastuzumab combined with pegylated liposomal doxorubicin in patients with metastatic breast cancer. phase II Study of the Hellenic Cooperative Oncology Group (HeCOG) with biomarker evaluation." @default.
- Q37406658 prefLabel "Trastuzumab combined with pegylated liposomal doxorubicin in patients with metastatic breast cancer. phase II Study of the Hellenic Cooperative Oncology Group (HeCOG) with biomarker evaluation." @default.
- Q37406658 prefLabel "Trastuzumab combined with pegylated liposomal doxorubicin in patients with metastatic breast cancer. phase II Study of the Hellenic Cooperative Oncology Group" @default.
- Q37406658 P1433 Q37406658-FEDCF91D-FC8F-4B2D-85ED-DF0EDF2DE468 @default.
- Q37406658 P1476 Q37406658-08F6F8A1-A7F6-4107-8DD2-9291623686AD @default.
- Q37406658 P2093 Q37406658-06CD08A3-1BC7-432F-A31D-4EE8328C2B1C @default.
- Q37406658 P2093 Q37406658-14BEDE77-1D36-431F-8F7A-90B2F7C4C417 @default.
- Q37406658 P2093 Q37406658-3285E94C-3401-41FD-A677-35B634C7B555 @default.
- Q37406658 P2093 Q37406658-567E2D8A-3845-4C64-9B9D-83D4ED9401D8 @default.
- Q37406658 P2093 Q37406658-648F34E5-18F3-4BD7-A9F7-F7B57FF885CA @default.
- Q37406658 P2093 Q37406658-968E3DA3-3C36-491E-9158-E194E5D04A22 @default.
- Q37406658 P2093 Q37406658-D0AB4CD5-52DF-482A-A2F5-70EC5FFEBB86 @default.
- Q37406658 P2093 Q37406658-E1655FDE-DE79-4C50-90BF-A979AB0C66DE @default.
- Q37406658 P2093 Q37406658-FC902A84-0121-4C0F-B301-64591694BD90 @default.
- Q37406658 P304 Q37406658-E1D85466-0F75-4E3E-8129-6B9916CDDEAB @default.
- Q37406658 P31 Q37406658-002ED466-2695-4D4B-972A-588B65F26DE8 @default.
- Q37406658 P356 Q37406658-469C0529-9B5F-4C51-9FDD-10A0106AEAAA @default.
- Q37406658 P407 Q37406658-E001A0DC-5E65-46EF-8292-4DC67D180867 @default.
- Q37406658 P433 Q37406658-8B4C628D-93C8-45AF-B970-B5F5A4F05126 @default.
- Q37406658 P478 Q37406658-FA794691-54DB-4C09-8CBD-82B3BA9A37FA @default.
- Q37406658 P50 Q37406658-4BEA7C25-3105-43D1-AC6B-B1B2D4159D2F @default.
- Q37406658 P50 Q37406658-60FD9D80-C1CA-4091-9333-6839B56FF12F @default.
- Q37406658 P577 Q37406658-E31E4C19-0650-4324-881F-9AC1315C6A6D @default.
- Q37406658 P698 Q37406658-D6043397-B53B-457C-9D30-5BF95413890F @default.
- Q37406658 P921 Q37406658-115BDBB4-446E-49CE-98CD-1DEFF926DAE9 @default.
- Q37406658 P921 Q37406658-33B05367-BE85-4113-945C-1C21DC005750 @default.
- Q37406658 P921 Q37406658-4FBD0E0C-F040-4F59-B5C0-5A594C131F02 @default.
- Q37406658 P921 Q37406658-AF838623-214A-49D0-BE65-205041BA9826 @default.
- Q37406658 P356 000207504 @default.
- Q37406658 P698 19262067 @default.
- Q37406658 P1433 Q2016300 @default.
- Q37406658 P1476 "Trastuzumab combined with pegylated liposomal doxorubicin in patients with metastatic breast cancer. phase II Study of the Hellenic Cooperative Oncology Group (HeCOG) with biomarker evaluation" @default.
- Q37406658 P2093 "Christos Christodoulou" @default.
- Q37406658 P2093 "Dimosthenis V Skarlos" @default.
- Q37406658 P2093 "Evangelia Razis" @default.
- Q37406658 P2093 "Evangelos Briasoulis" @default.
- Q37406658 P2093 "Evangelos Lianos" @default.
- Q37406658 P2093 "George Fountzilas" @default.
- Q37406658 P2093 "Helen Gogas" @default.
- Q37406658 P2093 "Ioannis Kostopoulos" @default.
- Q37406658 P2093 "Study of the Hellenic Cooperative Oncology Group" @default.
- Q37406658 P304 "275-285" @default.
- Q37406658 P31 Q13442814 @default.
- Q37406658 P356 "10.1159/000207504" @default.
- Q37406658 P407 Q1860 @default.
- Q37406658 P433 "4" @default.
- Q37406658 P478 "76" @default.
- Q37406658 P50 Q41163950 @default.
- Q37406658 P50 Q56432806 @default.
- Q37406658 P577 "2009-03-05T00:00:00Z" @default.
- Q37406658 P698 "19262067" @default.
- Q37406658 P921 Q181600 @default.
- Q37406658 P921 Q18936 @default.
- Q37406658 P921 Q412616 @default.
- Q37406658 P921 Q864574 @default.